HomeORMP • NASDAQ
add
Oramed Pharmaceuticals, Inc.
Nakaraang pagsara
$2.37
Sakop ng araw
$2.36 - $2.40
Sakop ng taon
$2.00 - $3.67
Market cap
95.13M USD
Average na Volume
102.70K
P/E ratio
24.03
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 3.09M | 6.77% |
Net na kita | -19.62M | -508.91% |
Net profit margin | — | — |
Kita sa bawat share | -0.48 | -500.00% |
EBITDA | -3.04M | -6.97% |
Aktuwal na % ng binabayarang buwis | -6.12% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 142.30M | -18.70% |
Kabuuang asset | 165.08M | -28.50% |
Kabuuang sagutin | 9.56M | -88.44% |
Kabuuang equity | 155.52M | — |
Natitirang share | 40.31M | — |
Presyo para makapag-book | 0.61 | — |
Return on assets | -4.42% | — |
Return on capital | -4.64% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -19.62M | -508.91% |
Cash mula sa mga operasyon | -7.10M | -923.20% |
Cash mula sa pag-invest | -34.26M | 54.39% |
Cash mula sa financing | -1.29M | -101.73% |
Net change in cash | -42.65M | -3,183.22% |
Malayang cash flow | -277.62K | 40.85% |
Tungkol
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
CEO
Itinatag
2006
Website
Mga Empleyado
15
